IW
SLS icon

Instrumental Wealth’s SELLAS Life Sciences SLS Stock Holding History

Instrumental Wealth’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Hold
44,914
– – 0.34% 32
2026
Q1 		$190K Hold
44,914
– – 0.12% 70
2025
Q4 		$221K Hold
44,914
– – 0.13% 64
2025
Q3 		$85.8K Buy
+44,914
New +$80K 0.06% 71

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
VH
Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return
FD
Financial Designs Claremont, California $187M AUM 14.59% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.4B AUM 23.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Instrumental Wealth's SLS Position: Q2 2026 in Review

Instrumental Wealth held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 44,914 shares worth $663K. The position accounts for 0.34% of the portfolio, ranked #32.

Instrumental Wealth first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 15 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Instrumental Wealth held 44,914 shares of SELLAS Life Sciences worth $663K as of Q2 2026.
  • Instrumental Wealth left its SELLAS Life Sciences share count unchanged in Q2 2026.
  • SELLAS Life Sciences made up 0.34% of Instrumental Wealth's portfolio in Q2 2026, its #32 holding.
  • Instrumental Wealth first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 15 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Instrumental Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.